{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:06Z","timestamp":1707523926184},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,19]]},"DOI":"10.7759\/cureus.49056","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T19:42:51Z","timestamp":1700422971000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Pattern of Leukocytoclastic Vasculitis in Granulomatosis With Polyangiitis"],"prefix":"10.7759","author":[{"given":"Sarah A","family":"Mullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia B","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Lloyd-McLennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Siller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey J","family":"Georgesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.005","article-title":"Skin involvement in cutaneous and systemic vasculitis","volume":"12","author":"Marzano AV","year":"2013","unstructured":"Marzano AV, Vezzoli P, Berti E. Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev. 2013, 12:467-76. 10.1016\/j.autrev.2012.08.005","journal-title":"Autoimmun Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab042","article-title":"Ear, nose, throat and airways disease in granulomatosis with polyangiitis","volume":"60","author":"Coates ML","year":"2021","unstructured":"Coates ML, Willcocks LC, Sivasothy P, Martinez Del Pero M. Ear, nose, throat and airways disease in granulomatosis with polyangiitis. Rheumatology (Oxford). 2021, 60:iii50-3. 10.1093\/rheumatology\/keab042","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002160","article-title":"Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry","volume":"8","author":"Pu\u00e9chal X","year":"2022","unstructured":"Pu\u00e9chal X, Iudici M, Pagnoux C, et al.. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry. RMD Open. 2022, 8:002160. 10.1136\/rmdopen-2021-002160","journal-title":"RMD Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.39812","article-title":"Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and Anca-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets","volume":"68","author":"Miloslavsky EM","year":"2016","unstructured":"Miloslavsky EM, Lu N, Unizony S, et al.. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and Anca-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets. Arthritis Rheumatol. 2016, 68:2945-52. 10.1002\/art.39812","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.016","article-title":"ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis","volume":"120","author":"Finkielman JD","year":"2007","unstructured":"Finkielman JD, Lee AS, Hummel AM, et al.. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007, 120:643.e9-14. 10.1016\/j.amjmed.2006.08.016","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt X","year":"2017","unstructured":"Bossuyt X, Cohen Tervaert JW, Arimura Y, et al.. Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017, 13:683-92. 10.1038\/nrrheum.2017.140","journal-title":"Nat Rev Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-022-05918-w","article-title":"Updates of ocular involvement in granulomatosis with polyangiitis","volume":"261","author":"Mei L","year":"2023","unstructured":"Mei L, Wang L, Yan H. Updates of ocular involvement in granulomatosis with polyangiitis. Graefes Arch Clin Exp Ophthalmol. 2023, 261:1515-23. 10.1007\/s00417-022-05918-w","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2023.03.004","article-title":"Treatment approaches to granulomatosis with polyangiitis and microscopic polyangiitis","volume":"49","author":"Berti A","year":"2023","unstructured":"Berti A, Cornec D, Dua AB. Treatment approaches to granulomatosis with polyangiitis and microscopic polyangiitis. Rheum Dis Clin North Am. 2023, 49:545-61. 10.1016\/j.rdc.2023.03.004","journal-title":"Rheum Dis Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone JH","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, et al.. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010, 363:221-32. 10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones RB","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, et al.. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010, 363:211-20. 10.1056\/NEJMoa0909169","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","author":"Hellmich B","year":"2023","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, et al.. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2023, 223764. 10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/186992-atypical-pattern-of-leukocytoclastic-vasculitis-in-granulomatosis-with-polyangiitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:36Z","timestamp":1707508356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/186992-atypical-pattern-of-leukocytoclastic-vasculitis-in-granulomatosis-with-polyangiitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.49056","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,19]]}}}